New York, NY, Sept. 08, 2017 -- In just under 30 days, cyclists from around the northeast will gather together in solidarity for young women diagnosed with breast cancer, biking over 200 miles and raising thousands of dollars for the support and education for women diagnosed at age 40 and under.
|
|||
YSC Tour De Pink kicks off Friday, October 6 outside Philadelphia, Pennsylvania and ends Sunday, October 8 in Long Branch, New Jersey. Riders will travel 211 miles through historic towns, picturesque rural communities, and iconic shore spots.
Participants can also join in for a single-day, 58-mile ride on Saturday, October 7 from Princeton to Asbury Park.
Tour de Pink is a fundraising event of Young Survival Coalition (YSC), the premier nonprofit dedicated to young women with breast cancer. The funds raised will help educate, empower and connect the more than 250,000 young American women who have faced breast cancer.
Now in its 13th year, Tour de Pink has generated more than $8 million in the name of young women affected by breast cancer. And Tour de Pink is more than just a bike ride: it’s a “rolling community” of survivors, partners, family and friends.
To learn more about YSC Tour de Pink®, visit: east.ysctourdepink.org
# # #
About Young Survival Coalition (YSC)®
Established in 1998, Young Survival Coalition (YSC) is the premier organization dedicated to young women with breast cancer. Founded by three young survivors, YSC began as a grassroots organization to advocate on behalf of all young women diagnosed with breast cancer to increase their length and quality of life. Based in New York City, with networks nationwide, YSC provides free resources, connections and educational materials so young women with breast cancer feel supported, empowered and hopeful. YSC seeks to educate and influence the medical, research and legislative communities to address breast cancer in young women, and to ensure that no young woman faces breast cancer alone. For more information, visit youngsurvival.org.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/eb1444c3-664f-48aa-a495-05d7626ffce6
Emily Helck Young Survival Coalition 6462573024 [email protected]


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Italy Fines Apple €98.6 Million Over App Store Dominance
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



